A detailed history of Gallacher Capital Management LLC transactions in Genmab A/S stock. As of the latest transaction made, Gallacher Capital Management LLC holds 11,958 shares of GMAB stock, worth $269,892. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,958
Previous 7,865 52.04%
Holding current value
$269,892
Previous $235 Million 27.74%
% of portfolio
0.16%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$25.13 - $30.27 $102,857 - $123,895
4,093 Added 52.04%
11,958 $301 Million
Q1 2024

May 06, 2024

BUY
$26.43 - $32.77 $31,504 - $39,061
1,192 Added 17.86%
7,865 $235 Million
Q4 2023

Feb 06, 2024

BUY
$27.94 - $35.44 $186,443 - $236,491
6,673 New
6,673 $212 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $14.9B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Gallacher Capital Management LLC Portfolio

Follow Gallacher Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gallacher Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gallacher Capital Management LLC with notifications on news.